Prostate Cancer
Ibex AI-Driven Prostate Cancer Screening Test Nets FDA Clearance
Ibex Prostate Detect is designed to help pathologists catch small and rare cancers in whole-slide images from tissue biopsies that they might've missed.
RedHill Biopharma's Opaganib Enters Phase II Trial With Nubeqa in Select Prostate Cancer Patients
Researchers will use a lipidomic biomarker test to select patients with a poor prognosis who may benefit from an investigational combination therapy.
Novartis Posts Strong Q4 Sales of Kisqali, Pluvicto
During 2024, the radiopharmaceutical Pluvicto achieved blockbuster status, while sales of the breast cancer drug Kisqali grew 46 percent compared to 2023.
Repare Therapeutics Shuffles Pipeline, Pauses Some Programs Pending Partnership
The firm will pause development of lunresertib and camonsertib while focusing on development of two newer programs.
Candel Therapeutics to Raise $80M in Public Stock and Warrants Offering
The firm plans to put the funds toward a biologics licensing application for its lead product candidate CAN-2409 in prostate cancer.